Sign Up Today and Learn More About GRO Biosciences Stock
Invest in or calculate the value of your shares in GRO Biosciences or other pre-IPO companies through EquityZen's platform.

GRO Biosciences Stock (GROB)
GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.
About GRO Biosciences Stock
Founded
2016
Headquarters
Boston, MA, US
Industries
Messaging and Telecommunications, Sports, Content and Publishing
GRO Biosciences Press Mentions
Stay in the know about the latest news on GRO Biosciences
Biotech layoff tracker: 21 companies cut 1,000 jobs in Q1 2025
bizjournals • Apr 01, 2025
Cuts and shake-up as GRObio reviews strategy
thepharmaletter • Mar 21, 2025
George Church spinout GRObio explores strategic alternatives 6 months after $60M series B
fiercebiotech • Mar 14, 2025
Compositions and methods of use for inteins
patents • Feb 08, 2025
GRO Biosciences Closes $60M Series B
vcnewsdaily • Aug 05, 2024
GRO Biosciences Management
Leadership team at GRO Biosciences
Co-Founder and Chief Executive Officer
Daniel J. Mandell
Co-Founder and Scientific Advisor
Ross Thyer

Join now and verify your accreditation status to gain access to:
- GRO Biosciences Current Valuation
- GRO Biosciences Stock Price
- GRO Biosciences Management
- Available deals in GRO Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- GRO Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- GRO Biosciences Revenue and Financials
- GRO Biosciences Highlights
- GRO Biosciences Business Model
- GRO Biosciences Risk Factors
- GRO Biosciences Research Report from SACRA Research
Trading GRO Biosciences Stock
How to invest in GRO Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like GRO Biosciences through EquityZen funds. These investments are made available by existing GRO Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell GRO Biosciences stock?
Shareholders can sell their GRO Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."